**Question:** In β-thalassemia, there is

A. reduced production of β-globin chains
B. decreased synthesis of HbA
C. increased degradation of β-globin chains
D. increased destruction of red blood cells

**Core Concept:**
β-Thalassemia is a group of inherited blood disorders characterized by reduced production of β-globin chains. The β-globin chains are one of the four components of hemoglobin (Hb), which transports oxygen from the lungs to the body's tissues and returns carbon dioxide back to the lungs. In β-thalassemia, the reduced production of β-globin chains leads to decreased hemoglobin synthesis and impaired oxygen transport, causing symptoms and complications associated with the condition.

**Why the Correct Answer is Right:**
In β-thalassemia, the correct answer A (reduced production of β-globin chains) is right because this reduced production leads to a decrease in the synthesis of HbA. HbA is the most stable form of hemoglobin, composed of two α-globin chains and two β-globin chains. The reduced production of β-globin chains results in an imbalance of α:β-globin chains, which alters the ratio of HbA to HbF (fetal hemoglobin). This imbalance causes ineffective erythropoiesis (red blood cell production) and leads to the characteristic features of β-thalassemia.

**Why Each Wrong Option is Incorrect:**

B. **Decreased synthesis of HbA:** This option is incorrect because the reduced production of β-globin chains directly affects the synthesis of HbA, not HbA itself.

C. **Increased degradation of β-globin chains:** This option is incorrect because the primary issue in β-thalassemia is reduced production of β-globin chains, not increased degradation.

D. **Increased destruction of red blood cells:** While increased destruction of red blood cells is a compensatory mechanism in β-thalassemia, this option does not address the primary cause of the condition, which is reduced production of β-globin chains.

**Clinical Pearl:**

β-Thalassemia is a group of inherited disorders caused by mutations in the β-globin genes, leading to reduced production of β-globin chains. These mutations can be silent or result in severe anemia, depending on the degree of β-globin chain synthesis impairment. In severe forms, patients may require regular blood transfusions and chelation therapy to manage complications such as iron overload. Understanding the correct answer and the reasons for incorrect options is essential for students to grasp the pathophysiology of β-thalassemia and differentiate it from other anemias with similar presentation.